<DOC>
	<DOCNO>NCT00161681</DOCNO>
	<brief_summary>The purpose study determine whether LNG/EE effective treatment menstrual cycle relate symptom .</brief_summary>
	<brief_title>Study Evaluating Levonorgestrel/Ethinyl Estradiol ( LNG/EE ) PMS</brief_title>
	<detailed_description />
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy woman age 18 49 year Regular 21 35 day menstrual cycle 3 month prior study visit 1 History menstrual cycle relate symptom determine investigator . Contraindication combination oral contraceptive Depression require hospitalization associate suicidal ideation within last 3 year Use antidepressants/anxiolytics within 10 day screen duration study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Levonorgestrel</keyword>
	<keyword>ethinyl estradiol</keyword>
	<keyword>premenstrual syndrome</keyword>
	<keyword>menstrual cycle relate symptom</keyword>
</DOC>